Enhanced C1GalT1 expression by transfection reduced the occurrence of Tn antigen on RTK member MET and inhibited HGF-induced MET activation and viability of HA22T and PLC5 hepatocellular cancer cells [34]. Here, C1GALT1 is linked to hepatocellular carcinoma.